Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Sept 2026 for Atrium Therapeutics, Inc., €87k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Husam Younis: trading record in brief
Husam Younis appears in our data through filings on Atrium Therapeutics, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 20 April 2026 and the latest from 18 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 22 September 2026, reports a share grant of €87k in Atrium Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Husam Younis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
11,216 shares@ US$8.95Common StockSEC:0001193125-26-397971:0
30,000 shares0Common StockSEC:0001193125-26-170906:0
2 of 2 declarations
